Adalimumab more cost effective than infliximab in early RA

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1499, 2005-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab more cost effective than infliximab in early RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Etanercept of greater value than adalimumab or infliximab for RA

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Etanercept of greater value than adalimumab or infliximab for RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Infliximab may be cost effective in severe, treatment-resistant RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Infliximab may be cost effective in severe, treatment-resistant RA

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite